Home / NEUMORA THERAPEUTICS, INC. (NMRA)

NEUMORA THERAPEUTICS, INC. (NMRA) Technical Analysis

Updated: 2026-05-01 03:19 UTC · Last close: 2.47 (+9.78%) · Support: 2.38 · Resistance: 2.54
NEUMORA THERAPEUTICS, INC. (NMRA) technical analysis page covering price structure, support and resistance, momentum conditions and a fundamentals snapshot from WOI Scanner.
⬇️ Support
2.38
⬆️ Resistance
2.54
🚀 Bullish Trigger
a clean close above 2.54 would strengthen the upside continuation case.
Quick Read
The nearest decision zone is framed by support around 2.38 and resistance near 2.54.
🔺 Technical Setup
RSI(14)
58.8
🎯 Decision Map
The nearest decision zone is framed by support around 2.38 and resistance near 2.54. A cleaner push through resistance would improve continuation odds, while a loss of support would weaken the current thesis. Pattern invalidation sits near 3.76, so a violation there would materially change the current setup narrative.
📊 Technical Summary
NEUMORA THERAPEUTICS, INC. (NMRA) finished the session at 2.47 (+9.78%). Price has slipped under the 50-day average but remains above the 200-day average, leaving the longer-term structure intact even as medium-term momentum softens. 20-day momentum is notably strong at +18.18%, with price remains inside its roughly 52-week range (0.62–3.59), while ATR14 volatility is elevated at roughly 7.27% of price. RSI(14) is 58.8, which keeps short-term momentum constructive without being overly stretched. RSI has been trending higher in recent sessions, indicating improving momentum conditions. MACD remains above its signal line, which keeps the momentum structure biased to the upside. The MACD histogram is positive and expanding, pointing to improving upside momentum. From a pattern perspective, the main active signal is Double top. The most important nearby levels are support at 2.38 and resistance at 2.54. Clearing resistance would improve continuation odds, while slipping below support would weaken the present setup. On the fundamentals side, the latest snapshot shows Net income: 236.93M · EPS (basic): -0.35. For a fuller technical read, the interactive view adds overlays, pattern context and broader chart structure.
💼 Fundamentals Snapshot
Source: sec
Company
NEUMORA THERAPEUTICS, INC.
CIK (SEC ID)
0001885522
Net Income
236.93M
EPS (Basic)
-0.35
Explore more
Adobe (ADBE) technical analysisSalesforce (CRM) technical analysisAdvanced Micro Devices (AMD) technical analysisOracle (ORCL) technical analysisCisco Systems (CSCO) technical analysisIntel (INTC) technical analysisQualcomm (QCOM) technical analysis
WOI OPEN ADVANCED ANALYSIS WORKSPACE
Note: This is an algorithmic technical snapshot (not financial advice).
NMRA Chart